The initial studies focusing on lipoprotein (a)[Lp (a)] and its role in atherosclerotic
cardiovascular disease were conducted exclusively in Whites. Subsequently, multiple large …

Levels of lipoprotein (a)[Lp (a)], a complex between an LDL-like lipid moiety containing one
copy of apoB, and apo (a), a plasminogen-derived carbohydrate-rich hydrophilic protein, are …

Over the last 10 years, there have been advances on several aspects of lipoprotein (a)
which are reviewed in the present article. Since the standard immunoassays for measuring …

Lipoprotein (a)[Lp (a)], is present only in humans, Old World nonhuman primates, and the
European hedgehog. Lp (a) has many properties in common with low-density lipoprotein …

Abstract Lipoprotein (a)[Lp (a)] has two main proteins, apoB100 and apo (a). High levels of
Lp (a) confer an increased risk for atherosclerotic cardiovascular disease. Most people have …

Lipoprotein (a)(Lp (a)) was first described approximately 40 years ago; interest in this entity
is largely derived from its putative role as a cardiovascular risk factor [1–3]. Underlying this …

ABSTRACT Lipoprotein (a)[Lp (a)] is a risk factor for cardiovascular disease. A size
polymorphism in the apolipoprotein (a)[apo (a)] gene, determined by the number of Kringle …

Objectives Observational and genetic studies have shown that lipoprotein (a)[L p (a)] levels
and apolipoprotein (a)[apo (a)] isoform size are both associated with coronary heart disease …

The importance of lipoprotein (a)—Lp (a)—as a cardiovascular (CV) risk marker has been
underscored by recent findings that CV risk is directly related to baseline Lp (a) levels, even …

Although elevated plasma concentrations of lipoprotein (a)(Lp (a)) have been identified as a
risk factor for coronary heart disease, the pathophysiologic and physiologic roles of Lp (a) …